{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:39:17Z","timestamp":1772271557202,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,11]]},"DOI":"10.7759\/cureus.45024","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:53:41Z","timestamp":1694418821000},"source":"Crossref","is-referenced-by-count":0,"title":["Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project"],"prefix":"10.7759","author":[{"given":"Dae Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry S","family":"Eichelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronak","family":"Chhaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Khadilkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiram","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Matar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic stenosis and cardiac amyloidosis: JACC review topic of the week","volume":"74","author":"Ternacle J","year":"2019","unstructured":"Ternacle J, Krapf L, Mohty D, et al.. Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol. 2019, 74:2638-51. 10.1016\/j.jacc.2019.09.056","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2009.04.005","article-title":"High prevalence of amyloid in 150 surgically removed heart valves--a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions","volume":"19","author":"Kristen AV","year":"2010","unstructured":"Kristen AV, Schnabel PA, Winter B, et al.. High prevalence of amyloid in 150 surgically removed heart valves--a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovasc Pathol. 2010, 19:228-35. 10.1016\/j.carpath.2009.04.005","journal-title":"Cardiovasc Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith CR","year":"2011","unstructured":"Smith CR, Leon MB, Mack MJ, et al.. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011, 364:2187-98. 10.1056\/NEJMoa1103510","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2021.11.001","article-title":"Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: a systematic review and meta-analysis","volume":"64","author":"Ho JS","year":"2022","unstructured":"Ho JS, Kor Q, Kong WK, et al.. Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: a systematic review and meta-analysis. Hellenic J Cardiol. 2022, 64:67-76. 10.1016\/j.hjc.2021.11.001","journal-title":"Hellenic J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.05.012","article-title":"Incremental value of global longitudinal strain for predicting survival in patients with advanced AL amyloidosis","volume":"2","author":"Lee Chuy K","year":"2020","unstructured":"Lee Chuy K, Drill E, Yang JC, et al.. Incremental value of global longitudinal strain for predicting survival in patients with advanced AL amyloidosis. JACC CardioOncol. 2020, 2:223-31. 10.1016\/j.jaccao.2020.05.012","journal-title":"JACC CardioOncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis: a practical approach","volume":"13","author":"Dorbala S","year":"2020","unstructured":"Dorbala S, Cuddy S, Falk RH. How to image cardiac amyloidosis: a practical approach. JACC Cardiovasc Imaging. 2020, 13:1368-83. 10.1016\/j.jcmg.2019.07.015","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer MS","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, et al.. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018, 379:1007-16. 10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in\u00a0patients undergoing carpal\u00a0tunnel\u00a0release","volume":"72","author":"Sperry BW","year":"2018","unstructured":"Sperry BW, Reyes BA, Ikram A, et al.. Tenosynovial and cardiac amyloidosis in\u00a0patients undergoing carpal\u00a0tunnel\u00a0release. J Am Coll Cardiol. 2018, 72:2040-50. 10.1016\/j.jacc.2018.07.092","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref10","article-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2021","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna; 2021."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o A","year":"2017","unstructured":"Casta\u00f1o A, Narotsky DL, Hamid N, et al.. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J. 2017, 38:2879-87. 10.1093\/eurheartj\/ehx350","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa170","article-title":"Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology\u00a0in patients referred for transcatheter aortic valve implantation","volume":"41","author":"Scully PR","year":"2020","unstructured":"Scully PR, Patel KP, Treibel TA, et al.. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology\u00a0in patients referred for transcatheter aortic valve implantation. Eur Heart J. 2020, 41:2759-67. 10.1093\/eurheartj\/ehaa170","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin\u00a0cardiac amyloidosis and\u00a0risk stratification using a novel\u00a0staging system","volume":"68","author":"Grogan M","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA, et al.. Natural history of wild-type transthyretin\u00a0cardiac amyloidosis and\u00a0risk stratification using a novel\u00a0staging system. J Am Coll Cardiol. 2016, 68:1014-20. 10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore JD","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M, et al.. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018, 39:2799-806. 10.1093\/eurheartj\/ehx589","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg FL","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 73:2872-91. 10.1016\/j.jacc.2019.04.003","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)01944-7","article-title":"Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography","volume":"40","author":"King DL","year":"2002","unstructured":"King DL, El-Khoury Coffin L, Maurer MS. Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography. J Am Coll Cardiol. 2002, 40:325-9. 10.1016\/s0735-1097(02)01944-7","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060596","article-title":"Targeted screening for transthyretin amyloid cardiomyopathy in patients with atrial fibrillation","volume":"146","author":"Prasad P","year":"2022","unstructured":"Prasad P, Howell S, Sanghai S, Stecker E, Henrikson CA, Masri A, Nazer B. Targeted screening for transthyretin amyloid cardiomyopathy in patients with atrial fibrillation. Circulation. 2022, 146:1730-2. 10.1161\/CIRCULATIONAHA.122.060596","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/181738-referral-for-cardiac-amyloidosis-in-patients-who-underwent-transcatheter-aortic-valve-replacement-results-of-the-quality-outcome-project","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:05:59Z","timestamp":1707491159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/181738-referral-for-cardiac-amyloidosis-in-patients-who-underwent-transcatheter-aortic-valve-replacement-results-of-the-quality-outcome-project"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.45024","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.06.17.23291544","asserted-by":"object"}]},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,11]]}}}